Dosage & Administration Drug label Financial assistance

Complera

(emtricitabine / rilpivirine / tenofovir disoproxil)

COMPLERA 200 MG / 25 MG / 300 MG Oral Tablet

Dosage & administration

* Testing: Prior to or when initiating COMPLERA, test for hepatitis B virus infection. Prior to initiation and during treatment with COMPLERA, on a clinically appropriate schedule, assess serum creatinine, estimated creatinine clearance, urine glucose, and urine protein in all patients. In patients with chronic kidney disease, also assess serum phosphorus.
* Recommended dosage in adults and pediatric patients weighing at least 35 kg: One tablet taken orally once daily with food.
* For pregnant patients who are already on COMPLERA prior to pregnancy and who are virologically suppressed (HIV-1 RNA less than 50 copies per mL), one tablet taken once daily may be continued. Lower exposures of rilpivirine were observed during pregnancy; therefore, viral load should be monitored closely.
* Renal impairment: Not recommended in patients with estimated creatinine clearance below 50 mL per minute.
* Recommended dosage with rifabutin coadministration: an additional 25 mg tablet of rilpivirine (Edurant) once per day taken concomitantly with COMPLERA and with a meal for the duration of the rifabutin coadministration.

drug label

Complera prescribing information

Contact Medical Science Liaison Report Adverse Event

financial assistance

Complera financial assistance options

Co-pay savings program

commercial only

Enroll in Patient Savings Program

Activate Co-Pay Card (if already have one)

Replace Co-Pay card (if lost one)

Learn More

Overview

Reduce patient OOP costs for drug (and occasionally for drug administration/infusion costs or drug-related test costs)

Patient benefit

A portion (or all) of patient OOP (deductible, copay), typically up to monthly and/or annual max

Patient eligibility

Patient must enroll or activate (may permit HCPs to enroll on patient’s behalf for HCP-administered drugs)
Generally, must have commercial insurance (rarely, may permit uninsured patients to use)
May never be used with government insurance

How to sign up

Cards may be downloadable digital cards or hard copies
Some pharmacos offer debit cards with pre-loaded copay benefit
Typically, available through multiple channels (e.g., rep to HCP to patient; pharmacy to patient; patient via website, Hub live agent, or copay vendor (live agent or IVR); patient and HCP via Hub enrollment form)
Some HCP-administered product programs permit HCPs to enroll on a patient’s behalf through via Hub form

Foundation programs

under insured

no insurance

goverment insurance

65+

OTHERPatient Assistance Program

Learn More

Overview

Charitable 501(c)(3) organizations provide direct cost-sharing and other support (e.g., travel, counseling) through disease-state funds to indigent patients on first-come first-served basis
These organizations may receive financial contributions from drug manaufacturers for particular disease-state funds that cannot provide funds directly to patients - the foundation must be independent/unaligned

Patient benefit

Patients apply for grants that cover a portion (or all) of their out-of-pocket costs (deductibles and co-pays) until the grant is exhausted

Patient eligibility

Patients must apply and meet eligibility criteria including income level (typically a multiple of federal poverty line), specific diagnosis, insurance status, etc.

How to sign up

Patients submit proof of out-of-pocket drug costs to charities for reimbursement

patient education

Complera patient education

Getting started on Complera

To share resource; ask patient to:

1.Pull out phone

2.Open camera

3.Scan QR code with camera

4.Tap link

Patient toolkit

Learn More

Other resources

Learn More

Complera FAQs

How is the dosage of Complera?Complera is available in 1 dosages, including 200-25-300 mg Tab

What does Complera treat?Complera treats Acquired Immunodeficiency Syndrome, HIV Infections and Chronic Hepatitis B

What is Complera made of?Complera contains emtricitabine / rilpivirine / tenofovir disoproxil which is a Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor

How Is Complera Administered?Complera is administered as a Oral Pill

What Are The Complera Mechanism Of Action?Complera mechanism of action is Non-Nucleoside Reverse Transcriptase Inhibitors or Nucleoside Reverse Transcriptase Inhibitors

FAQ Data Source

Complera

Dosage & administration

drug label

Complera prescribing information

financial assistance

Complera financial assistance options

Co-pay savings program

Foundation programs

patient education

Complera patient education

Getting started on Complera

Patient toolkit

Other resources

people also ask

Complera FAQs